Plasma phosphorylated tau 217 in relation to Alzheimer’s prevalence and cognition in Thailand
Pasin Hemachudha, Poosanu Thanapornsangsuth, Watayuth Luechaipanit, Thiravat Hemachudha · 2025
Read Plasma phosphorylated tau 217 in relation to Alzheimer’s prevalence and cognition in Thailand by Pasin Hemachudha, Poosanu Thanapornsangsuth, Watayuth Luechaipanit, Thiravat Hemachudha (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714997.txt.
Description
A blood test for Alzheimer's disease could change how whole countries count and catch the illness. Pasin Hemachudha and three co-authors measure plasma p-tau 217, a leading blood marker, in 71 Thai adults over forty, alongside standard memory and thinking tests. Using a cutoff set in a separate, biomarker-confirmed group, they estimate how many participants likely have the disease's biology.
The estimate came to 16.9 percent, lower than the roughly 30 percent an amyloid-based method would suggest. Marker levels correlated modestly with one cognitive test and weakly with another. The authors say the blood marker may flag people at risk of symptoms, but larger studies must prove its worth for screening and risk sorting. The study appears in 2025.
Catalog record
| CREATOR | Pasin Hemachudha, Poosanu Thanapornsangsuth, Watayuth Luechaipanit, Thiravat Hemachudha |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |